Common anti-apoptotic roles of parkin and α-synuclein in human dopaminergic cells

被引:62
作者
Machida, Y
Chiba, T
Takayanagi, A
Tanaka, Y
Asanuma, M
Ogawa, N
Koyama, A
Iwatsubo, T
Itoh, S
Jansen, PH
Shimizu, N
Tanaka, K
Mizuno, Y
Hattori, N [1 ]
机构
[1] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 113, Japan
[2] Tokyo Metropolitan Inst Med Sci, Dept Mol Oncol, Tokyo 113, Japan
[3] Nippon Vet & Anim Sci Univ, Dept Vet Hyg, Tokyo, Japan
[4] Okayama Univ, Grad Sch Med & Dent, Dept Brain Sci, Okayama, Japan
[5] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo, Japan
[6] Keio Univ, Dept Biol Mol, Tokyo, Japan
[7] Zlekenhuls Gelderse Vallei, Dept Neurol, Edo, Netherlands
[8] Fujita Hlth Univ, Sch Hlth Sci, Aichi, Japan
关键词
parkin; apoptosis; antisense; knockdown; neuroblastoma; synuclein doparnine metabolism; quinone;
D O I
10.1016/j.bbrc.2005.04.124
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkin. a product of the gene responsible for autosomal recessive juvenile parkinsonism, (AR-JP), is an important player in the pathogenic process of Parkinson's disease (PD). Despite numerous studies including search for the substrate of parkin as an E3 ubiquitin-protein ligase. the mechanism by which loss-of-function of parkin induces selective dopaminergic neuronal death remains unclear. Related to this issue. here we show that antisense knockdown of parkin causes apoptotic cell death of human dopaminergic SH-SY5Y cells associated with caspase activation and accompanied by accumulation of oxidative dopamine (DA) metabolites due to auto-oxidation of DOPA and DA. Forced expression of alpha-synuclein (alpha-SN), another familial PD gene product, prevented accumulation of oxidative DOPA/DA metabolites and cell death caused by parkin loss. Our findings indicate that both parkin and alpha-SN share a common pathway in DA metabolism whose abnormality leads to accumulation of oxidative DA metabolites and subsequent cell death. alpha 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:233 / 240
页数:8
相关论文
共 44 条
[1]   Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system [J].
Abeliovich, A ;
Schmitz, Y ;
Fariñas, I ;
Choi-Lundberg, D ;
Ho, WH ;
Castillo, PE ;
Shinsky, N ;
Verdugo, JMG ;
Armanini, M ;
Ryan, A ;
Hynes, M ;
Phillips, H ;
Sulzer, D ;
Rosenthal, A .
NEURON, 2000, 25 (01) :239-252
[2]   Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease [J].
Asanuma, M ;
Miyazaki, I ;
Ogawa, N .
NEUROTOXICITY RESEARCH, 2003, 5 (03) :165-176
[3]   α-synuclein gene triplication discovered in Parkinson's disease [J].
Bradbury, J .
LANCET NEUROLOGY, 2003, 2 (12) :715-715
[4]   α-synuclein locus duplication as a cause of familial Parkinson's disease [J].
Chartier-Harlin, MC ;
Kachergus, J ;
Roumier, C ;
Mouroux, V ;
Douay, X ;
Lincoln, S ;
Levecque, C ;
Larvor, L ;
Andrieux, J ;
Hulihan, M ;
Waucquier, N ;
Defebvre, L ;
Amouyel, P ;
Farrer, M ;
Destée, A .
LANCET, 2004, 364 (9440) :1167-1169
[5]   S-nitrosylation of Parkin regulates ubiquitination and compromises Parkin's protective function [J].
Chung, KKK ;
Thomas, B ;
Li, XJ ;
Pletnikova, O ;
Troncoso, JC ;
Marsh, L ;
Dawson, VL ;
Dawson, TM .
SCIENCE, 2004, 304 (5675) :1328-1331
[6]   Parkin ubiquitinates the α-synuclein-interacting protein, synphilin-1:: implications for Lewy-body formation in Parkinson disease [J].
Chung, KKK ;
Zhang, Y ;
Lim, KL ;
Tanaka, Y ;
Huang, H ;
Gao, J ;
Ross, CA ;
Dawson, VL ;
Dawson, TM .
NATURE MEDICINE, 2001, 7 (10) :1144-1150
[7]   Linking ubiquitin, parkin and synphilin-1 [J].
Ciechanover, A .
NATURE MEDICINE, 2001, 7 (10) :1108-1109
[8]   Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy [J].
Conway, KA ;
Lee, SJ ;
Rochet, JC ;
Ding, TT ;
Williamson, RE ;
Lansbury, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :571-576
[9]   Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct [J].
Conway, KA ;
Rochet, JC ;
Bieganski, RM ;
Lansbury, PT .
SCIENCE, 2001, 294 (5545) :1346-1349
[10]   Rare genetic mutations shed light on the pathogenesis of Parkinson disease [J].
Dawson, TM ;
Dawson, VL .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (02) :145-151